Article: Ibrutinib and idelalisib, the B-cell receptor antagonists available for use in daily clinical practice

2.42

SKU: product-article-18938 Category:

Description

Ibrutinib and idelalisib, the B-cell receptor antagonists available for use in daily clinical practice

Reviews

There are no reviews yet.

Be the first to review “Article: Ibrutinib and idelalisib, the B-cell receptor antagonists available for use in daily clinical practice”

Your email address will not be published. Required fields are marked *